FDA announces picks for likely 2016-2017 flu strains

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted unanimously Friday to adopt the World Health Organization’s recommendations for flu strains to be included in next season’s vaccine. Shortly, manufacturers will begin to develop vaccines based on the strains the WHO highlighted, to be ready for distribution by September or November. 

Advertisement

The American Pharmacists Association reports the following strains were recommended for the trivalent vaccine:

  • A/California/7/2009 (H1N1)pdm09-like virus
  • A/Hong Kong/4801/2014 (H3N2)-like virus
  • B/Brisbane/60/2008-like virus (B/Victoria lineage)

For the quadrivelent vaccine, the WHO recommended the inclusion of B/Phuket/3073/2013-like virus (B/Yamagata lineage).

The current flu season vaccine cocktail, which the CDC has found to be 59 percent effective, includes:

  • A/California/7/2009 (H1N1)pdm09-like virus
  • A/Switzerland/9715293/2013 (H3N2)-like virus
  • B/Phuket/3073/2013-like virus

This year’s quadrivalent vaccine included B/Brisbane/60/2008-like virus. 

More articles on infection control:

Uptick in flu cases causes Chicago hospitals to restrict visitors
8th week of flu season brings highest number of pediatric deaths so far
Researchers propose supply chain strategy that could reduce patient wait times for vaccines

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.